Nang Kuang Pharmaceutical Co. Ltd.

08/03/2022 | Press release | Distributed by Public on 08/03/2022 04:05

Announcement of the consolidated financial report for the 2nd quarter of 2022 approved by the board of directors

Close
Today's Information

Provided by: NANG KUANG PHARMACECUTICAL CO., LTD
SEQ_NO 1 Date of announcement 2022/08/03 Time of announcement 18:01:09
Subject 
 Announcement of the consolidated financial report for the
2nd quarter of 2022 approved by the board of directors
Date of events 2022/08/03 To which item it meets paragraph 31
Statement 
1.Date of submission to the board of directors or approval by the board of
 directors:2022/08/03
2.Date of approval by the audit committee:2022/08/03
3.Start and end dates of financial reports or annual self-assessed financial
 information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):
2022/01/01~2022/06/30
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):848609
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):301992
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):125970
7.Profit (loss) before tax accumulated from 1/1 to end of the period
 (thousand NTD):138192
8.Profit (loss) accumulated from 1/1 to end of the period
 (thousand NTD):115627
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):115627
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):1.14
11.Total assets end of the period (thousand NTD):3415786
12.Total liabilities end of the period
(thousand NTD):1241730
13.Equity attributable to owners of parent end of the
period (thousand NTD):2174056
14.Any other matters that need to be specified:None.